ABT Earnings
Abbott Laboratories next reports earnings on October 14, 2026. Track record: 4/4 beats.
Next Earnings In
Wednesday, October 14, 2026
Current Price
$105.70
EPS Estimate
Earnings Per Share
$1.42
+9.2% YoY
Trailing EPS
Last 12 months earnings
$3.09
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
17.4
Margin: 11.6%
Analyst Rating
24 analysts
Analyst Sentiment
Buy24 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | $1.28 | $1.31 | +2.6% | Beat |
| 2026-03-31 | $1.15 | $1.15 | +0.3% | Beat |
| 2025-12-31 | $1.49 | $1.50 | +0.3% | Beat |
| 2025-09-30 | $1.30 | $1.30 | +0.1% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $1.42 | $13B | +9.2% |
| Next Qtr(+1q) | $1.64 | $13.5B | +9.2% |
| Current Year(0y) | $5.52 | $50.3B | +7.1% |
| Next Year(+1y) | $6.06 | $54.6B | +9.9% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$1.42
Revenue Estimate
$13B
Annual EPS Est.
$5.52
+7.1% YoY
ABT Earnings FAQ
When is ABT's next earnings date?
Abbott Laboratories (ABT) is expected to report earnings on October 14, 2026. The consensus EPS estimate is $1.42.
Does ABT usually beat earnings estimates?
Abbott Laboratories has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is ABT's trailing EPS?
Abbott Laboratories's trailing twelve-month EPS is $3.09. This is calculated from the last four quarters of reported earnings.
What do analysts think about ABT?
24 Wall Street analysts cover Abbott Laboratories. The consensus rating is "Buy" with an average price target of $118.42, implying 12.0% upside from the current price.